lvrachЛечащий ВрачLechaschi Vrach1560-51752687-1181ООО «Издательство "Открытые системы"»lvrach-541Research ArticleСтатьиСравнение вариабельности массы миокарда левого желудочка по данным эхокардиографии, традиционной и усредненной электрокардиографии в аспекте оценки эфComparison of the left ventricle mass variability calculated from echocardiography, traditional and averaged electrocardiography in the evaluation of the effectiveness of antihypertensive therapyСеменкинА. А.SemenkinA. A.asemyonkin@mail.ruЧиндареваО. И.ChindarevaO. I.noemail@neicon.ruМахроваН. В.MakhrovaN. V.noemail@neicon.ruНечаеваГ. И.NechaevaG. I.noemail@neicon.ruПотаповВ. В.PotapovV. V.noemail@neicon.ruЖивиловаЛ. А.ZhivilovaL. A.noemail@neicon.ruСивковИ. Е.SivkovI. E.noemail@neicon.ruСеменоваЕ. В.SemenovaE. V.noemail@neicon.ruФГБОУ ВО ОмГМУ МЗ РФRussian FederationФГБУЗ ЗСМЦ ФМБА РоссииRussian FederationООО «Информационные Системы Сервиса Арт»Russian Federation201823062021071515Copyright © Семенкин А.А., Чиндарева О.И., Махрова Н.В., Нечаева Г.И., Потапов В.В., Живилова Л.А., Сивков И.Е., Семенова Е.В., 20212021Семенкин А.А., Чиндарева О.И., Махрова Н.В., Нечаева Г.И., Потапов В.В., Живилова Л.А., Сивков И.Е., Семенова Е.В.Semenkin A.A., Chindareva O.I., Makhrova N.V., Nechaeva G.I., Potapov V.V., Zhivilova L.A., Sivkov I.E., Semenova E.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.lvrach.ru/jour/article/view/541

Проведено сравнение вариабельности массы миокарда левого желудочка сердца (ММЛЖ), рассчитанной по данным ЭхоКГ, неусредненной и усредненной ЭКГ, и дана оценка эффективности этих методов в выявлении динамики ММЛЖ на фоне антигипертензивной терапии у больных артериальной гипертензией. Показано, что способ определения ММЛЖ по данным усредненной ЭКГ значительно превышает традиционный метод ЭКГ и ЭхоКГ по воспроизводимости, что при использовании его в клинической практике может обеспечить надежность индивидуализированной оценки изменений миокарда как при одномоментном исследовании, так и при их оценке в динамике. Использование метода в исследованиях с ЭКГ-контролем позволит сократить размер выборок или время для достижения статистически значимого результата.

The comparison of the variability of left ventricular mass (LVM) calculated from echocardiography, conventional and signalaveraged ECG and evaluation the effectiveness of these methods in the detection of the LVM changes during antihypertensive therapy were performed. It was found that the reproducibility of the signal-averaged ECG method of LVM calculation is significantly higher than the conventional one and echocardiography. The use of this method in clinical practice can provide reliability of individualized assessment of LVM changes on single examination and during follow-up. The use of signal-averaged ECG may reduce groups size or the study duration to achieve statistically significant difference in studies with ECG control. 

СимпозиумКардиологияАнгиологияВариабельность массы миокарда левого желудочкаУсредненная ЭКГАнтигипертензивная терапияleft ventricle mass variabilityaveraged ECGantihypertensive therapyReferencesVerdecchia P., Carini G., Circo A. et al. Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study // J Am Coll Cardiol. 2001. V. 38. № 7. Р. 1829–1835.Verdecchia P., Carini G., Circo A. et al. Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study // J Am Coll Cardiol. 2001. V. 38. № 7. Р. 1829–1835.Angeli F., Reboldi G., Poltronieri C. et al. The prognostic legacy of left ventricular hypertrophy: cumulative evidence after the MAVI study // J Hypertens. 2015. V. 33. № 11. P. 2322–2330.Angeli F., Reboldi G., Poltronieri C. et al. The prognostic legacy of left ventricular hypertrophy: cumulative evidence after the MAVI study // J Hypertens. 2015. V. 33. № 11. P. 2322–2330.Devereux R. B., Wachtell K., Gerdts E. et al. Prognostic significance of left ventricular mass change during treatment of hypertension // JAMA. 2004. V. 292. № 19. P. 2350–2356.Devereux R. B., Wachtell K., Gerdts E. et al. Prognostic significance of left ventricular mass change during treatment of hypertension // JAMA. 2004. V. 292. № 19. P. 2350–2356.Devereux B., Koren M., de Simone G. et al. Methods for detection of left ventricular hypertrophy: application to hypertensive heart disease // Eur Heart J. 1993. V. 14. P. 8–15.Devereux B., Koren M., de Simone G. et al. Methods for detection of left ventricular hypertrophy: application to hypertensive heart disease // Eur Heart J. 1993. V. 14. P. 8–15.Devereux R. Is ECG still useful for detection of the left ventricular hypertropy? // Circulation. 1990. V. 81. P. 1144–1146.Devereux R. Is ECG still useful for detection of the left ventricular hypertropy? // Circulation. 1990. V. 81. P. 1144–1146.De Vries S., Heesen W., Beltman F. et al. Prediction of the left ventricular mass from the electrocardiogram in systemic hypertension // Am J Cardiol. 1996. V. 77. № 11. Р. 974–978.De Vries S., Heesen W., Beltman F. et al. Prediction of the left ventricular mass from the electrocardiogram in systemic hypertension // Am J Cardiol. 1996. V. 77. № 11. Р. 974–978.Wolf H., Burggraf G., Cuddy E. et al. Prediction of left ventricular mass from the electrocardiogram // J Electrocardiol. 1991. V. 24. P. 121–127.Wolf H., Burggraf G., Cuddy E. et al. Prediction of left ventricular mass from the electrocardiogram // J Electrocardiol. 1991. V. 24. P. 121–127.Семенкин А. А., Чиндарева О. И., Махрова Н. В. и др. Определение массы миокарда левого желудочка по показателям усредненной электрокардиограммы // Сердечная недостаточность. 2016. Т. 17. № 5. С. 333–338.Семенкин А. А., Чиндарева О. И., Махрова Н. В. и др. Определение массы миокарда левого желудочка по показателям усредненной электрокардиограммы // Сердечная недостаточность. 2016. Т. 17. № 5. С. 333–338.Lang R. M., Badano L. P., Mor-Avi V. et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging // Journal of the American Society of Echocardiography. 2015. V. 28. № 1. Р. 1–35.Lang R. M., Badano L. P., Mor-Avi V. et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging // Journal of the American Society of Echocardiography. 2015. V. 28. № 1. Р. 1–35.Семенкин А. А., Сивков И. Е., Лебедев В. М., Миллер Т. С. Свидетельство о Государственной регистрации программы для ЭВМ «ECG HR» № 2011616724 (RU); 29.08.2011.Семенкин А. А., Сивков И. Е., Лебедев В. М., Миллер Т. С. Свидетельство о Государственной регистрации программы для ЭВМ «ECG HR» № 2011616724 (RU); 29.08.2011.Семенкин А. А., Чиндарева О. И., Махрова Н. В., Нечаева Г. И., Потапов В. В., Живилова Л. А., Семенова Е. В. Способ определения массы миокарда левого желудочка сердца у больных неосложненной артериальной гипертензией при помощи усредненной электрокардиографии. Пат. 2015151297, (RU); ГБОУ ВПО ОмГМУ Минздрава Росии (RU). № 2612822; заявл. 30.11.15; опубл. 13.03.17, Бюл. № 8.Семенкин А. А., Чиндарева О. И., Махрова Н. В., Нечаева Г. И., Потапов В. В., Живилова Л. А., Семенова Е. В. Способ определения массы миокарда левого желудочка сердца у больных неосложненной артериальной гипертензией при помощи усредненной электрокардиографии. Пат. 2015151297, (RU); ГБОУ ВПО ОмГМУ Минздрава Росии (RU). № 2612822; заявл. 30.11.15; опубл. 13.03.17, Бюл. № 8.Bland J., Altman D. Statistical methods for assessing agreement between two measures of clinical measurement // Lancet. 1986. V. 1 (8476). Р. 307–310.Bland J., Altman D. Statistical methods for assessing agreement between two measures of clinical measurement // Lancet. 1986. V. 1 (8476). Р. 307–310.Петри А., Сэбин К. Наглядная статистика в медицине. М.: Гэотар-Мед. 2003. С. 87–89.Петри А., Сэбин К. Наглядная статистика в медицине. М.: Гэотар-Мед. 2003. С. 87–89.Collins H., Kronenberg M., Byrd B. Reproducibility of left ventricular mass measurements by two-dimensional and M-mode echocardiography // J Am Coll Cardiol. 1989. V. 14. № 3. H. 672–676.Collins H., Kronenberg M., Byrd B. Reproducibility of left ventricular mass measurements by two-dimensional and M-mode echocardiography // J Am Coll Cardiol. 1989. V. 14. № 3. H. 672–676.Himelman R., Cassidy M., Landzberg J., Schiller N. Reproducibility of quantitative two-dimensional echocardiography // Am Heart J. 1988. V. 115. № 2. Р. 425–431.Himelman R., Cassidy M., Landzberg J., Schiller N. Reproducibility of quantitative two-dimensional echocardiography // Am Heart J. 1988. V. 115. № 2. Р. 425–431.Palmieri V., Dahl?f B., De Quattro V. et al. Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective Randomized Study Evaluating Regression of Ventricular Enlargement // J Am Coll Cardiol. 1999. V. № 34 (5). Р. 1625–1632.Palmieri V., Dahl?f B., De Quattro V. et al. Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective Randomized Study Evaluating Regression of Ventricular Enlargement // J Am Coll Cardiol. 1999. V. № 34 (5). Р. 1625–1632.Agabiti-Rosei E., Ambrosioni E., Finardi G. et al. Perindopril versus captopril: efficacy and acceptability in an italian multicenter trial // Am J Med. 1992. № 92 (4 B). Р. 79–83.Agabiti-Rosei E., Ambrosioni E., Finardi G. et al. Perindopril versus captopril: efficacy and acceptability in an italian multicenter trial // Am J Med. 1992. № 92 (4 B). Р. 79–83.Graettinger W., Lipson J., Klein R. et al. Comparison of antihypertensive therapies by noninvasive techniques // Chest. 1989. V. 96. P. 74–79.Graettinger W., Lipson J., Klein R. et al. Comparison of antihypertensive therapies by noninvasive techniques // Chest. 1989. V. 96. P. 74–79.Devereux R., Palmieri V., Sharpe N. et al. Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade–based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension the prospective randomized enalapril study evaluating regression of ventricular enlargement (PRESERVE) trial // Circulation. 2001. V. 104. P. 1248–1254.Devereux R., Palmieri V., Sharpe N. et al. Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade–based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension the prospective randomized enalapril study evaluating regression of ventricular enlargement (PRESERVE) trial // Circulation. 2001. V. 104. P. 1248–1254.Koldas L., Ayan F., Ikitimur B. Short term effects of rilmenidine on left ventricular hypertrophy and systolic and diastolic function in patients with essential hypertension comparison with an angiotensin converting enzyme inhibitor and a calcium antagonist // Jpn Heart J. 2003. V. 44. V. 693–704.Koldas L., Ayan F., Ikitimur B. Short term effects of rilmenidine on left ventricular hypertrophy and systolic and diastolic function in patients with essential hypertension comparison with an angiotensin converting enzyme inhibitor and a calcium antagonist // Jpn Heart J. 2003. V. 44. V. 693–704.Matsuzaki K., Mukai M., Sumimoto T., Murakami E. Effects of ace inhibitors versus calcium antagonists on left ventricular morphology and function in patients with essential hypertension // Hypertens Res. 1997. V. 20. P. 7–10.Matsuzaki K., Mukai M., Sumimoto T., Murakami E. Effects of ace inhibitors versus calcium antagonists on left ventricular morphology and function in patients with essential hypertension // Hypertens Res. 1997. V. 20. P. 7–10.Moroni C., Tolone S., Lopreiato F. et al. Effects of losartan on left ventricular mass: a three-year follow-up in elderly hypertensives with myocardial hypertrophy despite successful conventional antihypertensive treatment // European Review for Medical and Pharmacological Sciences. 2017. V. 21. P. 1323–1328.Moroni C., Tolone S., Lopreiato F. et al. Effects of losartan on left ventricular mass: a three-year follow-up in elderly hypertensives with myocardial hypertrophy despite successful conventional antihypertensive treatment // European Review for Medical and Pharmacological Sciences. 2017. V. 21. P. 1323–1328.Rakic D., Rumboldt Z., Bagatin J., Polic S. Effects of four antihypertensive monotherapies on cardiac mass and function in hypertensive patients with left ventricular hypertrophy: randomized prospective study // Croat Med J. 2002. V. 43. P. 672–679.Rakic D., Rumboldt Z., Bagatin J., Polic S. Effects of four antihypertensive monotherapies on cardiac mass and function in hypertensive patients with left ventricular hypertrophy: randomized prospective study // Croat Med J. 2002. V. 43. P. 672–679.Roman M., Alderman M., Pickering T. et al. Differential effects of angiotensin converting enzyme inhibition and diuretic therapy on reductions in ambulatory blood pressure, left ventricular mass, and vascular hypertrophy // Am J Hypertens. 1998. V. 11 (4 Pt 1). P. 387–396.Roman M., Alderman M., Pickering T. et al. Differential effects of angiotensin converting enzyme inhibition and diuretic therapy on reductions in ambulatory blood pressure, left ventricular mass, and vascular hypertrophy // Am J Hypertens. 1998. V. 11 (4 Pt 1). P. 387–396.Cuspidi C., Sala С., Negri F. et al. Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies // Journal of Human Hypertension. 2012. V. 26. P. 343–349.Cuspidi C., Sala С., Negri F. et al. Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies // Journal of Human Hypertension. 2012. V. 26. P. 343–349.Cuspidi C., Rescaldanic M., Sala C. et al. Prevalence of electrocardiographic left ventricular hypertrophy in human hypertension: an updated review // Journal of Hypertension. 2012. V. 30. P. 2066–2073.Cuspidi C., Rescaldanic M., Sala C. et al. Prevalence of electrocardiographic left ventricular hypertrophy in human hypertension: an updated review // Journal of Hypertension. 2012. V. 30. P. 2066–2073.

The authors declare that there are no conflicts of interest present.